Provider
QP59-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Tarpeyo™ (budesonide)
Program effective Date: Jul 13, 2022
Search Results
Displaying 1821 - 1830 of 3661 results
Provider
P44-22 New Medical, Medical Drug and Behavioral Health Policy Management Updates: Effective October 3, 2022
Program effective Date: Aug 01, 2022
Provider
P45-22 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama
Program effective Date: Aug 01, 2022
Provider
P46-22 eviCore Healthcare Specialty Utilization Management (UM) Program: Medical Oncology Drug Prior Authorization Updates
Program effective Date: Aug 01, 2022
Provider
QP66-22 Commercial Pharmacy Benefit Exclusion for Amvuttra™ and Skyrizi®
Program effective Date: Aug 10, 2022
Provider
QP67-22 MHCP Pharmacy Benefit Exclusion for Amvuttra™, Pemetrexed, and Skyrizi®
Program effective Date: Aug 10, 2022
Provider
QP68-22 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective October 1, 2022
Program effective Date: Aug 10, 2022
Provider
QP60-22 MHCP Pharmacy Benefit Exclusion for Camcevi™ (leuprolide)
Program effective Date: Jul 13, 2022
Provider
2022 July Bulletins
Program effective Date: Jul 01, 2022